DREADDs (designer receptors exclusively activated by designer drugs): chemogenetic tools with therapeutic utility.

Abstract excerpt

In the past decade, emerging synthetic biology technologies such as chemogenetics have dramatically transformed how pharmacologists and systems biologists deconstruct the involvement of G protein-coupled receptors (GPCRs) in a myriad of physiological and translational settings. Here we highlight a specific chemogenetic application that extends the utility of the concept of RASSLs (receptors activated solely by...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Drug Design
• Share to Gene Expression Regulation
• Share to Ligands